SARcode Bioscience Acquired By Shire
Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments based on future milestones for the company. SARcode was venture backed by Alta Partners, Clarus Ventures, Rho Ventures, Sofinnova Ventures, and Sunesis Pharmaceuticals.
posted on Tuesday, March 26, 2013
Related companies:
SARcode
Related stories:
> SARcode Bioscience Gets $44M
> SARcode Gets Series A
> Crystal Bioscience Acquired By Ligand For Up To $30.5M
> Twist Bioscience Buys Genome Compiler
> Twist Bioscience Gets $37M
silicontap.com Home